Medindia
Medindia LOGIN REGISTER
Advertisement

Compounding Pharmacy Market Worth $12 Billion by 2022

Friday, May 11, 2018 Research News
Advertisement
PUNE, India, May 11, 2018 /PRNewswire/ --
Advertisement

Compounding pharmacy market research explores recently announces this report and added on ReportsnReports.com. Main players are Fagron, B. Braun Melsungen, Fresenius, Wedgewood Pharmacy, Dougherty's Pharmacy, and Village Compounding Pharmacy. The analysts forecast global compounding pharmacy market will earn a revenue of about USD 12 billion by 2022.
Advertisement

Get complete report on Compounding Pharmacy Market spread across 115 pages, analyzing 6 major companies and providing 81 data exhibits now available at http://www.reportsnreports.com/reports/1500647-global-compounding-pharmacy-market-2018-2022.html .

Commenting on the compounding pharmacy market report, an analyst says one trend in the market is increasing prevalence of hormonal imbalance. Factors such as growing geriatric population, unhealthy eating habits of people, consumption of medications, stress, and increasing prevalence of thyroid, diabetes, and tumors, are driving the rising incidences of hormonal imbalance. This also results in physical and mental issues.

According to the report, one driver in the compounding pharmacy market is increase in healthcare and pharmaceutical spending. Proportionally, pharmaceutical spending is also increasing due to the increasing demand for medications. The growing incidences of chronic diseases are encouraging the consumers to visit compounding pharmacies.

Order a copy of Global Compounding Pharmacy Market 2018-2022 report at http://www.reportsnreports.com/purchase.aspx?name=1500647 .

Further, the compounding pharmacy market report states that one challenge in the market is non-availability of insurance. Health insurance plans do not cover compounded drugs. Hence, people must spend out-of-pocket to purchase compounded medications. This is a challenge for people from low-income groups. This report covers the present scenario and the growth prospects of the global Compounding Pharmacy Market for 2018-2022.

Another related report is Global Compounding Pharmacy Market Research Report 2018, In this report, the global Compounding Pharmacy market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Global Compounding Pharmacy market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, PharMEDium Services, Cantrell Drug, Advanced Pharma, Dougherty's Pharmacy, Institutional Pharmacy Solutions, Lorraine's Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy. Browse complete Global Compounding Pharmacy Market report at http://www.reportsnreports.com/reports/1344542-global-compounding-pharmacy-market-research-report-2018.html .

Explore other new reports on Pharmaceuticals Market at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact: Hrishikesh Patwardhan 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411001. Maharashtra, India. + 1 888 391 5441 [email protected]

Connect with Us:  LinkedIn: http://www.linkedin.com/company/reportsnreports RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

SOURCE ReportsnReports

Sponsored Post and Backlink Submission


Latest Press Release on Research News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close